Phenotypic stratification of Low-grade Glioma using multimodal MRI via outcome-weighted integrative clustering
Open Access
- 4 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-15
Abstract
Background: Low-grade glioma (LGG) is a diverse group of primary brain tumors, whose molecular heterogeneity hinders classification by traditional pathological methods. Accurate phenotypic subtyping of LGG is essential for capturing tumor characteristics and optimizing clinical management. We intend to identify LGG phenotypic subtypes based on multimodal magnetic resonance imaging (MRI) data, enhancing prognosis evaluation and optimizing treatment strategy. Methods: This was a retrospective multicenter study, and data were drawn from the First Hospital of Shanxi Medical University (FHSXMU) and Shanxi Provincial People’s Hospital (SPPH) (FHSXMU/SPPH cohort, n = 162), and The Cancer Genome Atlas (TCGA)/The Cancer Imaging Archive (TCIA) (TCGA/TCIA cohort, n = 118). In the FHSXMU/SPPH cohort, LGG phenotypic subtypes were identified using the outcome-weighted integrative clustering method (survClust) based on multimodal MRI data (CE-T1 and T2FLAIR). A multivariate Cox proportional hazards model was applied to evaluate survival differences between subtypes. Statistical comparisons between subtypes were performed, and the statistically significant MRI features were utilized to predict clinically relevant biomarkers – isocitrate dehydrogenase (IDH) mutation combined with O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation. Five models were constructed, including fused kernel partial least squares with the genetic algorithm (GA-fKPLS), logistic regression, random forest, support vector machine, and k -nearest neighbor. In the TCGA/TCIA cohort, we validated the identified phenotypic subtypes and further explored their biological characteristics by analyzing pathway activity and immune infiltration levels using mRNA expression data. Results: Two distinct LGG phenotypic subtypes were identified in the FHSXMU/SPPH cohort, and validated in the TCGA/TCIA cohort. In the FHSXMU/SPPH cohort, significant differences in pathological grade, MGMT promoter status, IDH genotype, survival status, tumor volume, and survival outcome ( HR : 2.553, 95% CI : [1.226–5.315]) between the two subtypes ( P < 0.05). Compared to other four models, the GA-fKPLS model exhibited superior predictive performance (AUC: 0.809). In the TCGA/TCIA cohort, two LGG phenotypic subtypes showed significant differences in pathway activities (JAK-STAT, TNF-α, p53) and immune cell infiltration (M2 macrophages, T cell regulatory, Monocytes) ( P adj < 0.05). Conclusion: This study identified two LGG phenotypic subtypes and potential biomarkers, offering supplementary information for clinical evaluation and treatment decision-making. GraphicalKeywords
Funding Information
- National Natural Science Foundation of China (82071893, U21A20386, 82473739)
- Applied Basic Research Project of Shanxi Province, China (202303021211204, 202303021211130)
- Shanxi Province Research Funding Project for Returned Overseas Scholars (2024-081)
- Shanxi Province Higher Education “Billion Project” Science and Technology Guidance Project
This publication has 62 references indexed in Scilit:
- Texture Feature Differentiation of Glioblastoma and Solitary Brain Metastases Based on Tumor and Tumor-brain InterfaceAcademic Radiology, 2024
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent GlioblastomaJAMA Oncology, 2020
- Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade gliomaEuropean Radiology, 2019
- A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgeryEuropean Radiology, 2019
- Methodological consensus on clinical proton MRS of the brain: Review and recommendationsMagnetic Resonance in Medicine, 2019
- The Microenvironmental Landscape of Brain TumorsCancer Cell, 2017
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaCell, 2016
- Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade gliomaClinical Neurology and Neurosurgery, 2015
- Loss of p53 cooperates with K‐ras activation to induce glioma formation in a region‐independent mannerGlia, 2013
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspectiveActa Neuropathologica, 2010